Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by GEORGE A CALIN and CHANG-GONG LIU.
GEORGE A CALIN
Connection Strength
1.454
CHANG-GONG LIU
  1. The role of p19 and p21 H-Ras proteins and mutants in miRNA expression in cancer and a Costello syndrome cell model. BMC Med Genet. 2015 Jul 03; 16:46.
    View in: PubMed
    Score: 0.130
  2. MiR-15a and miR-16-1 cluster functions in human leukemia. Proc Natl Acad Sci U S A. 2008 Apr 01; 105(13):5166-71.
    View in: PubMed
    Score: 0.079
  3. MicroRNA expression profiling using microarrays. Nat Protoc. 2008; 3(4):563-78.
    View in: PubMed
    Score: 0.078
  4. Expression profiling of microRNA using oligo DNA arrays. Methods. 2008 Jan; 44(1):22-30.
    View in: PubMed
    Score: 0.078
  5. Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. Cancer Cell. 2007 Sep; 12(3):215-29.
    View in: PubMed
    Score: 0.076
  6. Tumor suppressor functions of ARLTS1 in lung cancers. Cancer Res. 2007 Aug 15; 67(16):7738-45.
    View in: PubMed
    Score: 0.076
  7. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med. 2005 Oct 27; 353(17):1793-801.
    View in: PubMed
    Score: 0.067
  8. Familial cancer associated with a polymorphism in ARLTS1. N Engl J Med. 2005 Apr 21; 352(16):1667-76.
    View in: PubMed
    Score: 0.064
  9. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci U S A. 2004 Aug 10; 101(32):11755-60.
    View in: PubMed
    Score: 0.061
  10. An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc Natl Acad Sci U S A. 2004 Jun 29; 101(26):9740-4.
    View in: PubMed
    Score: 0.061
  11. Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer. Mol Cancer. 2013 Feb 14; 12:13.
    View in: PubMed
    Score: 0.028
  12. Disrupted microRNA expression caused by Mecp2 loss in a mouse model of Rett syndrome. Epigenetics. 2010 Oct 01; 5(7):656-63.
    View in: PubMed
    Score: 0.023
  13. GAM/ZFp/ZNF512B is central to a gene sensor circuitry involving cell-cycle regulators, TGF{beta} effectors, Drosha and microRNAs with opposite oncogenic potentials. Nucleic Acids Res. 2010 Nov; 38(21):7673-88.
    View in: PubMed
    Score: 0.023
  14. Hematopoietic differentiation: a coordinated dynamical process towards attractor stable states. BMC Syst Biol. 2010 Jun 16; 4:85.
    View in: PubMed
    Score: 0.023
  15. Reprogramming of miRNA networks in cancer and leukemia. Genome Res. 2010 May; 20(5):589-99.
    View in: PubMed
    Score: 0.023
  16. Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol. 2010 Feb; 11(2):136-46.
    View in: PubMed
    Score: 0.022
  17. Unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks. J Biol Chem. 2009 Oct 02; 284(40):27487-99.
    View in: PubMed
    Score: 0.022
  18. Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells. Blood. 2009 May 28; 113(22):5568-74.
    View in: PubMed
    Score: 0.021
  19. A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function. Nat Genet. 2009 Mar; 41(3):365-70.
    View in: PubMed
    Score: 0.021
  20. Specific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase Itch for degradation. Blood. 2009 Apr 16; 113(16):3744-53.
    View in: PubMed
    Score: 0.021
  21. MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer. Cancer Res. 2008 Dec 15; 68(24):10307-14.
    View in: PubMed
    Score: 0.021
  22. Expression of microRNAs and protein-coding genes associated with perineural invasion in prostate cancer. Prostate. 2008 Aug 01; 68(11):1152-64.
    View in: PubMed
    Score: 0.020
  23. Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer Res. 2008 Aug 01; 68(15):6162-70.
    View in: PubMed
    Score: 0.020
  24. Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. Proc Natl Acad Sci U S A. 2008 May 13; 105(19):7004-9.
    View in: PubMed
    Score: 0.020
  25. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA. 2008 Jan 30; 299(4):425-36.
    View in: PubMed
    Score: 0.019
  26. MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood. 2008 Mar 15; 111(6):3183-9.
    View in: PubMed
    Score: 0.019
  27. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol. 2007 Oct 15; 179(8):5082-9.
    View in: PubMed
    Score: 0.019
  28. MicroRNA signatures in human ovarian cancer. Cancer Res. 2007 Sep 15; 67(18):8699-707.
    View in: PubMed
    Score: 0.019
  29. Micro-RNA profiling in kidney and bladder cancers. Urol Oncol. 2007 Sep-Oct; 25(5):387-92.
    View in: PubMed
    Score: 0.019
  30. mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer. Mol Cancer. 2007 Aug 23; 6:54.
    View in: PubMed
    Score: 0.019
  31. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res. 2007 Jul 01; 67(13):6092-9.
    View in: PubMed
    Score: 0.019
  32. Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene. 2007 Nov 29; 26(54):7590-5.
    View in: PubMed
    Score: 0.019
  33. CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control. Proc Natl Acad Sci U S A. 2007 Feb 20; 104(8):2750-5.
    View in: PubMed
    Score: 0.018
  34. MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. Oncogene. 2007 Jun 14; 26(28):4148-57.
    View in: PubMed
    Score: 0.018
  35. A microRNA signature of hypoxia. Mol Cell Biol. 2007 Mar; 27(5):1859-67.
    View in: PubMed
    Score: 0.018
  36. Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res. 2006 Dec 15; 66(24):11590-3.
    View in: PubMed
    Score: 0.018
  37. MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol. 2006 Oct 10; 24(29):4677-84.
    View in: PubMed
    Score: 0.018
  38. Expression profiles of micro RNA in proliferating and differentiating 32D murine myeloid cells. J Cell Physiol. 2006 Jun; 207(3):706-10.
    View in: PubMed
    Score: 0.017
  39. MicroRNA fingerprints during human megakaryocytopoiesis. Proc Natl Acad Sci U S A. 2006 Mar 28; 103(13):5078-83.
    View in: PubMed
    Score: 0.017
  40. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell. 2006 Mar; 9(3):189-98.
    View in: PubMed
    Score: 0.017
  41. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A. 2006 Feb 14; 103(7):2257-61.
    View in: PubMed
    Score: 0.017
  42. The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci U S A. 2005 Dec 27; 102(52):19075-80.
    View in: PubMed
    Score: 0.017
  43. MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc Natl Acad Sci U S A. 2005 Dec 13; 102(50):18081-6.
    View in: PubMed
    Score: 0.017
  44. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A. 2005 Sep 27; 102(39):13944-9.
    View in: PubMed
    Score: 0.017
  45. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005 Aug 15; 65(16):7065-70.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.